XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Financial Instruments
9 Months Ended
Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments Financial Instruments
The following is a summary of available-for-sale marketable securities, as of September 30, 2025 and December 31, 2024, respectively (in thousands):
September 30, 2025
Amortized CostUnrealized Gains
Unrealized Losses
Fair Value
Marketable securities:
Corporate securities (1)
$47,459 $130 $(3)$47,586 
U.S. agency securities3,090 — — 3,090 
Total Marketable securities$50,549 $130 $(3)$50,676 
(1)Comprised primarily of corporate bonds
December 31, 2024
Amortized CostUnrealized Gains
Unrealized Losses
Fair Value
Marketable securities:
Corporate securities (1)
$43,008 $$(74)$42,943 
U.S. agency securities3,097 — (4)3,093 
Total Marketable securities$46,105 $$(78)$46,036 
(1)Comprised primarily of corporate bonds
As of September 30, 2025, the fair values of available-for-sale marketable securities, by remaining contractual maturity, were as follows (in thousands):
Due within one year$33,903 
Due in one to five years16,773 
Total$50,676 
The Company typically invests in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. Fair values were determined for each individual security in the investment portfolio.
The Company does not believe that any unrealized losses are attributable to credit-related factors based on its evaluation of available evidence. To determine whether a decline in value is related to credit loss, the Company evaluates, among other factors: the extent to which the fair value is less than the amortized cost basis, changes to the rating of the security by a rating agency and any adverse conditions specifically related to an issuer of a security or its industry. The Company does not intend to sell the instruments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be maturity. Unrealized gains and losses on marketable securities are presented net of tax.